Clinical studies recruiting near Jefferson

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Phase 1 · Johnson & Johnson Enterprise Innovation Inc. · NCT06116786 A Registry for People With T-cell Lymphoma
Phase N/A · Memorial Sloan Kettering Cancer Center · NCT05978141 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · National Cancer Institute (NCI) · NCT05564390 A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Phase 1/Phase 2 · IDEAYA Biosciences · NCT07174583 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · NRG Oncology · NCT05624996 Spinal Cord Injury Registry - North American Clinical Trials Network
Phase N/A · Robert G. Grossman, MD · NCT00178724 Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
NA · Thomas Jefferson University · NCT07234968 Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
Phase 1/Phase 2 · Novartis Pharmaceuticals · NCT06704269 PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Phase 3 · Duke University · NCT07232069 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Alliance for Clinical Trials in Oncology · NCT07321652 A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Phase 1 · Fate Therapeutics · NCT06308978 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · National Cancer Institute (NCI) · NCT05691478 EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
Phase N/A · Thomas Jefferson University · NCT07478016 A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Phase 1 · Clasp Therapeutics, Inc. · NCT06778863 A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Phase 1 · Crossbow Therapeutics, Inc. · NCT06994676 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · True North Neurology, Merz Investigational Site #0010508 · Merz Therapeutics GmbH · NCT07018700 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Eli Lilly and Company · NCT06890598 Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · PrECOG, LLC. · NCT06538038 A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Phase 2 · Fore Biotherapeutics · NCT05503797 Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 1 · Amgen · NCT04221542 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Children's Oncology Group · NCT04322318 Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
Phase 3 · Thomas Jefferson University · NCT05470205 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Eli Lilly and Company · NCT06937086 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Merck Sharp & Dohme LLC · NCT06077760 Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · McFarland Clinic - Jefferson · SWOG Cancer Research Network · NCT06769126 Vivistim Registry for Paired VNS Therapy (GRASP)
Phase N/A · MicroTransponder Inc. · NCT05301140 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Ochsner Clinic Foundation · Gilead Sciences · NCT06051617 A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours
Phase 1/Phase 2 · Orion Corporation, Orion Pharma · NCT06725758 Neoadjuvant Tebentafusp for Uveal Melanoma
Phase 2 · Thomas Jefferson University · NCT06414590

Look up another city

Look up another condition